| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 149.8 | 141.0 | 135.4 |
| Other income | 4.7 | 4.1 | 4.8 |
| Total income | 154.5 | 145.2 | 140.2 |
| Profit before exceptional items & tax | 28.6 | 27.6 | 20.9 |
| Exceptional items | 7.6 | 1.3 | 0.0 |
| Profit before tax | 21.0 | 26.4 | 20.9 |
| Net profit | 16.2 | 19.5 | 15.2 |
| Operating margin | 13.6% | 18.2% | 14.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +6.60% |
|---|---|
| Net profit, quarter on quarter | -16.90% |
| Revenue, year on year | +10.60% |
NSE results filing, NSE: AMRUTANJAN. Figures extracted from the filing.
Amrutanjan Health Care Ltd: key numbers
- Share price
- ₹506.35
- Market cap
- ₹1,464 Cr
- Revenue (annual)
- ₹502.6 Cr
- Net profit (annual)
- ₹57.92 Cr
- P/E (TTM)
- 27.1×Sector 50.4×
- Promoter holding
- 46.52%+0.00% QoQ
- FII holding
- 2.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amrutanjan Health Care Ltd
All →Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited held its 89th AGM on September 23, 2026. The meeting transacted business including the adoption of accounts, dividend declaration, and director re-appointment.
Amrutanjan Health Care Investor Presentation: Key Takeaways
Amrutanjan reported 9.48% revenue growth in Q1 FY27, driven by Women's Hygiene (21%) and Beverages (11.34%). Profitability was hit by a one-time INR 2.02 Cr lease rent provision.
- Call
- Guides 10% growth
Amrutanjan Health Care Q1 FY27 Results: Net Profit ₹4.4 Cr, Down 47.0% YoY
Amrutanjan Health Care Ltd reported revenue from operations of ₹103 Cr (+9.6% YoY) and net profit of ₹4.4 Cr (-47.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹4.4 Cr · -47.0% YoY
Amrutanjan Health Care Earnings Call: Key Takeaways
Amrutanjan reported 11.23% revenue growth for FY26 with significant 37.2% jump in Q4 profit before exceptional items. Strategy focuses on power brands, distribution expansion, and digitization.
Amrutanjan Health Care Earnings Call: Key Takeaways
Amrutanjan reported FY26 net sales of ₹502.55 Cr (up 11.23%) and PAT of ₹57.92 Cr (up 13.95%). Strategy focuses on expanding Pain Management, Women's Hygiene, and new Personal Care categories.